Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
DeFi Development (DFDV) PT Lowered to $4.70 at Cantor Fitzgerald: Has an Edge
-
Bitmine Immersion Technologies (BMNR) PT Lowered to $30.30 at Cantor Fitzgerald
-
Realty Income (O) Reiterated at Neutral by Cantor Fitzgerald as New JV Announced
-
Surgery Partners (SGRY) Reiterated at Overweight by Cantor Fitzgerald
-
Universal Health Services (UHS) Reiterated at Neutral by Cantor Fitzgerald: Set-up Difficult
-
Tenet Healthcare (THC) Reiterated at Overweight by Cantor Fitzgerald on Consensus Cut
-
HCA Healthcare (HCA) Reiterated at Overweight by Cantor Fitzgerald on Attractive Set-up
-
Viking Therapeutic (VKTX) Reiterated at Overweight by Cantor Fitzgerald
-
Design Therapeutics (DSGN) Reiterated at Overweight by Cantor Fitzgerald
-
Cantor Fitzgerald Starts Forward Industries (FWDI) at Overweight
-
Cantor Fitzgerald Starts Cypherpunk Technologies (CYPH) at Overweight
-
Patented Proprietary Recovery Process Demonstrated at Gediktepe
-
Osprey Acquisition Corp. III prices $261M IPO on Nasdaq
-
Osprey Acquisition Corp. III Announces Pricing of $261,000,000 Initial Public Offering
-
Cantor Equity Partners I, Inc. Announces Postponement of Shareholder Meeting to 10:00 AM Eastern Time on July 10, 2026
-
Nuvectis Pharma prices $100M public offering at $20 per share
-
Nuvectis Pharma Announces Pricing of $100 Million Public Offering of Common Stock
-
Cantor Fitzgerald Starts ProMIS Neurosciences (PMN) at Overweight
-
Nuvectis Pharma launches public stock offering via Cantor
-
Nuvectis Pharma Announces Proposed Public Offering of Common Stock
-
Form 24F-2NT CANTOR FITZGERALD INFRAS For: Mar 31
-
Cantor Fitzgerald Reiterates Overweight Rating on Strategy (MSTR), PT $212, '
-
WEX Inc. (WEX) PT Lowered to $152 at Cantor Fitzgerald on Recent Commentary
-
Lam Research (LRCX) PT Raised to $500 at Cantor Fitzgerald: Gaining Most Share in Group
-
KLA Corporation (KLAC) PT Raised to $325 at Cantor Fitzgerald: Limited EPS Upside
-
Intel (INTC) PT Raised to $150 at Cantor Fitzgerald: Outperforming in Accelerator Market
-
AMD (AMD) PT Raised to $700 at Cantor Fitzgerald: Has 'Greatest momentum in Compute'
-
Applied Materials (AMAT) PT Raised to $850 at Cantor Fitzgerald: Limited EPS Upside
-
Advanced Energy Industries (AEIS) PT Raised to $450 at Cantor Fitzgerald
-
Analog Devices (ADI) PT Raised to $550 at Cantor Fitzgerald: Fundamental Backdrop Strong
-
Rivian Automotive (RIVN) Reiterated at Neutral by Cantor Fitzgerald on R2 Launch
-
Cantor Fitzgerald Starts Quantinuum Inc (QNT) at Overweight
-
Cantor Fitzgerald Starts Liftoff Mobile (LFTO) at Overweight
-
Securitize SPAC deal to raise $400M, NYSE listing set for July
-
Securitize and Cantor Equity Partners II Business Combination Expected to Raise Approximately $400 million in Gross Proceeds and Announce Expected Closing of Business Combination and NYSE Listing
-
KULR Technology extends ATM offering pause through September 2026
-
KULR Technology Group Reaffirms Non-Dilutive Growth Strategy, Extends At-the-Market Offering Pause Through September 2026
-
Rubrik (RBRK) Reiterated at Overweight by Cantor Fitzgerald on Strong Q1 Beat
-
Remitly Global (RELY) Reiterated at Overweight by Cantor Fitzgerald as Revenue Growing
-
ON Semiconductor (ON) Reiterated at Neutral by Cantor Fitzgerald Amid SYNA Acquisition
-
Palo Alto Networks (PANW) Reiterated at Overweight by Cantor Fitzgerald on Revenue Beat
-
Palo Alto Networks (PANW) Reiterated at Overweight by Cantor Fitzgerald on Revenue Beat
-
Okta (OKTA) Reiterated at Overweight by Cantor Fitzgerald as New Products Drive Beat
-
Fortinet (FTNT) Reiterated at Neutral by Cantor Fitzgerald on 'Strongest Beats'
-
JFrog (FROG) Reiterated at Overweight by Cantor Fitzgerald on Revenue Beat
-
CrowdStrike (CRWD) Reiterated at Overweight by Cantor Fitzgerald on Modest Beat
-
Nuvation Bio prices $250M convertible notes offering due 2032
-
Nuvation Bio Announces Pricing of Upsized Offering of $250.0 million of Convertible Senior Notes
-
Form NPORT-P Cantor Fitzgerald Commod For: Apr 30
-
Helus Pharma closes $50M share offering at $4.85 per share

